Hot Products

Caffeic acid
Catalog No: CFN99190

Caffeic acid has antidiabetic, antioxidant, anticarcinogenic, and anti-inflammatory activities, it can suppress ultraviolet B(UVB)-induced COX-2 expression by blocking Fyn kinase activity, inhibits HBV-DNA replication as well as HBsAg production, also reduces serum DHBV level in DHBV-infected duckling model. Caffeic acid may be used as designed novel therapeutic drugs for Parkinson's disease by inhibiting α-synuclein fibrillation.

Caffeic acid 4-O-glucoside
Catalog No: CFN91682

Caffeic acid 4-O-glucoside showed significant axonal elongation effects on Aβ25-35-induced atrophy. Caffeic acid 4-O-glucoside has inhibitory effects on the formation of advanced glycation end products (AGEs), the activity of angiotensin-converting (ACE) and acetylcholinesterase (AChE) enzymes.Caffeic acid 4-O-glucoside has radical-scavenging effect.

Caffeic acid phenethyl ester
Catalog No: CFN90554

Caffeic acid phenethyl ester is a potent and specific inhibitor of NF-κB activation, and also displays neuroprotective, antioxidant, immunomodulatory and antiinflammatory activities; it also has potential beneficial effects on the wound healing of nasal mucosa in the rat.Caffeic acid phenethyl ester has potential preventive effects on myringosclerosis development after myringotomy and ventilation tube insertion.

Caffeine
Catalog No: CFN99004

Caffeine has anxiolytic-like activity, can have both positive and negative effects on anxiety. It inhibits glucose transport by binding at the GLUT1 nucleotide-binding site.

Caffeoyl alcohol
Catalog No: CFN70348

Reference standards.

Caffeoylmalic acid
Catalog No: CFN70354

Caffeoylmalic acid has neurosedative and antioxidant activities.

Caftaric acid
Catalog No: CFN00384

Caftaric acid is an inhibitor of the protein-protein interactions mediated by the Src-family kinases, which has anti-mutagenicity. Caftaric acid is the major dietary polyphenol present in various foods, it before methamphetamine injections can prevent liver toxicity and oxidative stress.

Cajanin
Catalog No: CFN98419

Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug. Cajanin has strong mitogenic as well as differentiation-promoting effects on osteoblasts that involved subsequent activation of MEK-Erk and Akt pathways.

Cajanine
Catalog No: CFN95448

Cajanine, a stilbenic component isolated from Cajanus cajan L., was identified as a potent HCV inhibitor (EC50 = 3.17 ± 0.75 μM). Cajanine promotes osteogenic differentiation and proliferation of human bone marrow mesenchymal stem cells. Cajanine promotes osteoblast proliferation and mineralized osteoid tissue formation in HOS TE85 cells, while inhibiting osteoclast derivation.

Calceolarioside A
Catalog No: CFN98522

Calceolarioside A shows potent activity against visceral leishmaniasis. It can induce a dose-related aggregant effect on rabbit platelets, which may be partly related to a calcium-dependent mechanism. Calceolarioside A also has potent antioxidative activity, it displays stronger scavenging potential with IC50 values of (4.15 +/- 0.07, 40.32 +/- 0.09, 2.26 +/- 0.03 microM) for OH, total ROS and scavenging of ONOO(-), respectively.